Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.109316
Revised: June 3, 2025
Accepted: August 25, 2025
Published online: March 20, 2026
Processing time: 279 Days and 9.8 Hours
In the United States, colorectal cancer is the third most prevalent non-skin cancer, causing 8% of cancer-related deaths. The most effective way to decrease cancer morbidity and mortality is cancer screening. However, individuals who identify as lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ+) are less likely to utilize cancer screening services compared to the general population. To understand the barriers to effective colorectal cancer screening in the LGBTQ+ population and recommend solutions, we conducted a critical review of the lite
Core Tip: Colorectal cancer is the third most common non-skin cancer in the United States, yet lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ+) individuals are less likely to undergo screening, contributing to healthcare disparities. This critical literature minireview, covering studies up to March 2024, examines barriers to colorectal cancer screening in the LGBTQ+ population across patient, provider, institutional, and policy levels. Key challenges include social stigma, lack of provider awareness, and insufficient culturally competent care. Proposed solutions include provider training, enhancing screening access, and adopting patient-centered models. The review emphasizes the need for a holistic, multi-level approach to ensure equitable cancer screening and improved outcomes for LGBTQ+ individuals.
